Talk:Anoxic depolarization in the brain

Latest comment: 10 years ago by Lemnaminor in topic Neuroprotective agents: potential references

Neuroprotective agents: potential references

edit

The section is not sourced very well: only 1 primary reference. Some possible sources to improve it:

  • Fisher, M. (2010). "New Approaches to Neuroprotective Drug Development". Stroke. 42 (1 Suppl): S24–S27. doi:10.1161/STROKEAHA.110.592394. PMID 21164111.
  • Savitz, S. I.; Fisher, M. (2007). "Future of neuroprotection for acute stroke: In the aftermath of the SAINT trials". Annals of Neurology. 61 (5): 396–402. doi:10.1002/ana.21127. PMID 17420989.
  • Auriel, E.; Bornstein, N. M. (2010). "Neuroprotection in acute ischemic stroke - current status". Journal of Cellular and Molecular Medicine. 14 (9): 2200–2202. doi:10.1111/j.1582-4934.2010.01135.x. PMID 20716132.
  • Tuttolomondo, A.; Di Sciacca, R.; Di Raimondo, D.; Arnao, V.; Renda, C.; Pinto, A.; Licata, G. (2009). "Neuron protection as a therapeutic target in acute ischemic stroke". Current topics in medicinal chemistry. 9 (14): 1317–1334. doi:10.2174/156802609789869646. PMID 19849659.
  • Ginsberg, M. D. (2008). "Neuroprotection for ischemic stroke: Past, present and future". Neuropharmacology. 55 (3): 363–389. doi:10.1016/j.neuropharm.2007.12.007. PMC 2631228. PMID 18308347.

Any takers? -- (talk) 16:41, 12 December 2013 (UTC)Reply